PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $441,000 | -51.1% | 11,002 | -54.5% | 0.07% | -45.5% |
| Q1 2022 | $902,000 | +40.7% | 24,164 | +40.2% | 0.12% | +86.2% |
| Q3 2021 | $641,000 | +58.7% | 17,239 | +101.9% | 0.06% | -3.0% |
| Q1 2021 | $404,000 | +42.3% | 8,540 | +44.4% | 0.07% | +103.0% |
| Q4 2019 | $284,000 | -75.5% | 5,914 | -80.8% | 0.03% | -72.0% |
| Q1 2019 | $1,161,000 | +45.9% | 30,832 | +32.9% | 0.12% | +28.3% |
| Q4 2018 | $796,000 | -40.9% | 23,200 | -19.1% | 0.09% | +24.3% |
| Q3 2018 | $1,348,000 | +202.9% | 28,690 | +18.1% | 0.07% | +155.2% |
| Q2 2017 | $445,000 | +45.0% | 24,300 | +111.5% | 0.03% | +93.3% |
| Q3 2015 | $307,000 | -89.2% | 11,487 | -80.6% | 0.02% | -86.4% |
| Q2 2015 | $2,853,000 | +96.2% | 59,274 | +148.1% | 0.11% | +89.7% |
| Q1 2015 | $1,454,000 | – | 23,889 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |